Rising controversy over function of FDA and Medicare in selling anti-amyloid medicine given restricted profit, excessive price, extreme side-effects
The War Over Whether Medicare Should Pay For The New Anti-Alzheimer’s Drugs (Forbers): The powerful Alzheimer’s Disease lobby is struggleing...
